-
Evonik to produce commercial quantities of the drug substance vonoprazan for use in VOQUEZNA™ TRIPLE PAK™ and DUAL PAK™, and other products containing vonoprazan
-
Supply security through production at sites in Europe and North America
-
Agreement strengthens Evonik’s track record as leading contract development and manufacturing organization (CDMO)
ESSEN, Germany, Oct. 10, 2022 /PRNewswire/ — Evonik has entered into a long-term supply…